Announcements Trials

Browse Landscape

Phase

Phase NA 7 Phase 1/2 1 Phase 1 1

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 424 Carcinoma, Non-Small-Cell Lung 92 Neoplasm Metastasis 69 Neoplasms 60 Carcinoma, Renal Cell 54 Lymphoma, T-Cell, Cutaneous 52 Ovarian Neoplasms 46 Squamous Cell Carcinoma of Head and Neck 42 Breast Neoplasms 40 Colorectal Neoplasms 38 Stomach Neoplasms 37 Skin Neoplasms 35 Lymphoma 32 Mycosis Fungoides 31 Carcinoma, Merkel Cell 31 Uveal Melanoma 30 Triple Negative Breast Neoplasms 29 Lung Neoplasms 29 Sezary Syndrome 28 Lymphoma, Non-Hodgkin 28 Lymphoma, Follicular 27 Hodgkin Disease 27 Pancreatic Neoplasms 26 Uterine Cervical Neoplasms 25 Sarcoma 25 Lymphoma, Large B-Cell, Diffuse 24 Leukemia, Lymphocytic, Chronic, B-Cell 24 Lymphoma, B-Cell, Marginal Zone 23 Carcinoma, Hepatocellular 23 Lymphoma, Mantle-Cell 22

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 1/2 × Nevus × Dermatologic × Clear all

NCT04364230 2024-07-16

Mel66

University of Virginia

Phase 1/2 Completed

Uveal Melanoma, Melanoma, Nevus

Data powered by HemOnc (CC BY 4.0) Colophon ⚡